David Evendon-Challis is chief scientific officer and head of R&D for Bayer’s Consumer Health Division and is a member of the Consumer Health Executive Committee. He is responsible for worldwide innovation and product development, from scoping and ideation through delivering innovation to the market via internal and external development. Over the past 17 years, David has worked across regulatory, communications and public affairs, sustainability, and product development. He joined Bayer in January 2020 from RB where he spent eight years in R&D leadership roles of increasing responsibility. Prior to this, he worked at companies including Kimberly-Clark, Salterbaxter MSL, and the Engine Group.